Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Frontiers in Immunology|July 10, 2023
Targeted immune activation in pediatric solid tumors: opportunities to complement local control approachesEmily P Vonderhaar, Michael B Dwinell, Brian T CraigJournal for Immunotherapy of Cancer|May 1, 2019
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse modelsWeiqing Jing, Donna McAllister, Emily P Vonderhaar, et al.Journal of Virology|January 8, 2016
Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus InfectionPhilip T Lange, Eric J Darrah, Emily P Vonderhaar, et al.Cellular and Molecular Gastroenterology and Hepatology|February 6, 2021
STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic CancerEmily P Vonderhaar, Nicholas S Barnekow, Donna McAllister, et al.Cureus|March 4, 2026
Optimal Timing of Initial Surveillance MRI Following Treatment of Brain Metastases With Stereotactic Radiation: A Comparison of Six Weeks Versus Three MonthsEmily P Vonderhaar-Meister, Timothy A Lin, Anne Li, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|January 17, 2017
Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinomaIshan Roy, Kathleen A Boyle, Emily P Vonderhaar, et al.Pageof 1